{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T21:41:38Z","timestamp":1771623698877,"version":"3.50.1"},"reference-count":12,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Case Reports"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Dapagliflozin, though beneficial in heart failure, can rarely cause euglycemic ketoacidosis even in non\u2010diabetic patients. Clinicians should maintain a high index of suspicion for metabolic acidosis in patients on SGLT2 inhibitors presenting with unexplained illness, regardless of blood glucose level.<\/jats:p>","DOI":"10.1002\/ccr3.71818","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T17:46:11Z","timestamp":1767807971000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Euglycemic Ketoacidosis Induced by Dapagliflozin in a Non\u2010Diabetic Patient With Cardiac Amyloidosis"],"prefix":"10.1002","volume":"14","author":[{"given":"Salhamoud Abdelfatah Saleh","family":"Hamoud","sequence":"first","affiliation":[{"name":"Department of Medicine University Hospitals Plymouth NHS Trust  Plymouth UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellie","family":"Harding","sequence":"additional","affiliation":[{"name":"Department of Medicine University Hospitals Plymouth NHS Trust  Plymouth UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.12.012"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv728"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1884"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0843"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1380"},{"issue":"2","key":"e_1_2_14_7_1","first-page":"288","article-title":"Euglycaemic Ketoacidosis in a Non\u2010Diabetic Patient on Empagliflozin for Heart Failure With Reduced Ejection Fraction","volume":"11","author":"Thawabi M.","year":"2021","journal-title":"Journal of Community Hospital Internal Medicine Perspectives"},{"issue":"3","key":"e_1_2_14_8_1","first-page":"165","article-title":"Management of Diabetic Ketoacidosis: A Consensus Statement of the Arab Society of Paediatric and Adult Endocrinology and Diabetes (ASPAED)","volume":"8","author":"Eledrisi M. S.","year":"2024","journal-title":"Diabetes Research and Clinical Practice"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024438"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.078915"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2017.07.004"},{"issue":"3","key":"e_1_2_14_12_1","first-page":"e1334","article-title":"Euglycaemic Ketoacidosis in a Non\u2010Diabetic Patient on SGLT2 Inhibitor: A Case Report and Pathophysiological Insights","volume":"107","author":"Monnier L.","year":"2022","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-9032"}],"container-title":["Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccr3.71818","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ccr3.71818","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccr3.71818","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T07:17:58Z","timestamp":1769066278000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccr3.71818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1002\/ccr3.71818"],"URL":"https:\/\/doi.org\/10.1002\/ccr3.71818","archive":["Portico"],"relation":{},"ISSN":["2050-0904","2050-0904"],"issn-type":[{"value":"2050-0904","type":"print"},{"value":"2050-0904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-10-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e71818"}}